VR Logo

Cadila Healthcare Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1995

Chairman: Pankaj R Patel

Managing Director: Sharvil P Patel

Group: Cadila

Listing: NSE: CADILAHC, BSE: 532321

Headquarters: Ahmedabad, Gujarat

Website: www.zyduscadila.com

Key Facts

Market cap: R 39,710.98 Cr

Revenue (TTM): R 14,396.70 Cr

Earnings (TTM): R 1,330.70 Cr

Cash: R 1,177.70 Cr

Total Debt: R 7,999.30 Cr

Promoters' ownership: 74.88%

Liquidity: High

52 Week range: R 202.00 - 411.60

Face value: R1.00

Shares outstanding: 1,02,37,42,600

10 Years Aggregate:

  • CFO: 11,605.30 Cr
  • EBITDA: 18,986.90 Cr
  • Net Profit: 12,308.80 Cr

Stock Performance

Time Period Cadila Healthcare S&P BSE Sensex S&P BSE Healthcare
YTD55.74-8.7038.59
1 month8.114.5613.87
3 months21.4519.7423.09
1 Year77.122.6349.59
3 Years-9.405.2210.26
5 Years0.625.931.38
10 Years11.897.5512.78
As on 05-Aug-2020
Year Cadila Healthcare S&P BSE Sensex S&P BSE Healthcare
2019-27.3514.38-3.55
2018-19.525.87-5.89
201721.5527.910.49
20167.201.95-12.88
20151.60-5.0315.06
2014100.2829.8947.43
2013-9.908.9822.55